FDA — authorised 30 October 1978
- Marketing authorisation holder: ALCON
- Status: approved
FDA authorised Natacyn on 30 October 1978
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 30 October 1978.
ALCON holds the US marketing authorisation.